• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT C16000 PROCESSING MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT C16000 PROCESSING MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE Back to Search Results
Catalog Number 03L77-01
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/31/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer observed falsely elevated sodium result generated by the architect c16000 processing module for a patient.The sample was repeated, and the result was within the normal range.The following data was provided: customer¿s reference range: 135 to 145 mmol/l.Initial sodium result = 196 mmol/l; repeat result = 139 mmol/l.No impact to patient management was reported.
 
Additional Manufacturer Narrative
The abbott field service representative (fsr) reviewed the instrument logs and recommended replacement of the aero c8k 1ml syr.The customer replaced the part and the issue was resolved.There were no additional service or complaint issues on or around the date this complaint was initiated that may have contributed to this issue.The instrument service history for the (b)(6) verifies no subsequent issues have been reported related to discrepant patient results after service intervention.Trending review determined normal complaint activity for the issue for the products.Device history record review did not show any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.Based on the investigation, no deficiency for the architect c16000, serial # (b)(6) or the aero c8k 1ml syr was identified.
 
Event or Problem Description
The customer observed falsely elevated sodium result generated by the architect c16000 processing module for a patient.The sample was repeated, and the result was within the normal range.The following data was provided: customer¿s reference range: 135 to 145 mmol/l.Initial sodium result = 196 mmol/l; repeat result = 139 mmol/l.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT C16000 PROCESSING MODULE
Common Device Name
ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key22738281
Report Number3016438761-2025-00461
Device Sequence Number7125365
Product Code JJE
UDI-Device Identifier00380740005924
UDI-Public(01)00380740005924
Combination Product (Y/N)N
Initial Reporter CountryCH
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number03L77-01
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/31/2025
Supplement Date Received by Manufacturer08/28/2025
Initial Report FDA Received Date08/07/2025
Supplement Report FDA Received Date09/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/01/2017
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CC1CT SAMP DIL, 01E48-20, UNKNOWN.; CC1CT SAMP DIL, 01E48-20, UNKNOWN.
Patient SexUnknown
-
-